GLOBAL LIFE SCIENCE VENTURES
Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance, advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerla... nd, GLSV acted as one team with a global perspective. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.
GLOBAL LIFE SCIENCE VENTURES
Industry:
Financial Services Life Science Venture Capital
Founded:
1996-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Apache Euro 1and1 Symantec.cloud Thomson Reuters Corporate Solutions
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-01-23 | Binx Health | Global Life Science Ventures investment in Series D - Binx Health | 35 M USD |
| 2015-01-29 | Binx Health | Global Life Science Ventures investment in Series C - Binx Health | 20 M USD |
| 2012-06-21 | Santaris Pharma | Global Life Science Ventures investment in Venture Round - Santaris Pharma | 12 M USD |
| 2010-07-16 | Action Pharma | Global Life Science Ventures investment in Series C - Action Pharma | 6.3 M USD |
| 2009-12-29 | Coapt Systems | Global Life Science Ventures investment in Debt Financing - Coapt Systems | 3.72 M USD |
| 2009-09-23 | Agendia | Global Life Science Ventures investment in Series E - Agendia | 23 M USD |
| 2007-12-30 | Santaris Pharma | Global Life Science Ventures investment in Series C - Santaris Pharma | 20.4 M EUR |
| 2007-08-28 | Agendia | Global Life Science Ventures investment in Series D - Agendia | 34 M USD |
| 2007-03-29 | Coapt Systems | Global Life Science Ventures investment in Series E - Coapt Systems | 22.6 M USD |
| 2007-03-29 | Nitec Pharma AG | Global Life Science Ventures investment in Series B - Nitec Pharma AG | 26 M USD |